Experimental prediction of the natural evolution of antibiotic resistance

Genetics

Volumn 163, Issue 4, 2003, Pages 1237-1241

  Barlow, Miriam ^a   Hall, Barry G ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; PIPERACILLIN; TEM BETA LACTAMASE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; EVOLUTION; GENE; IN VITRO STUDY; MUTAGENESIS; PREDICTION; PRIORITY JOURNAL; TEM GENE;

BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE; EVOLUTION;

EID: 0037396711     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BARLOW, M., and B. G. HALL, 2002 Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the TEM β-lactamase. Genetics 160: 823-832.
2. BLAZQUEZ, J., M. I. MOROSINI, M. C. NEGRI and F. BAQUERO, 2000 Selection of naturally occurring extended-spectrum TEM betalactamase variants by fluctuating beta-lactam pressure. Antimicrob. Agents Chemother. 44: 2182-2184.
3. CHANAL, C., R. BONNET, C. DE CHAMPS, D. SIROT, R. LABIA et al., 2000 Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital. Antimicrob. Agents Chemother. 44: 1930-1935.
4. COHEN, M. L., 2000 Changing patterns of infectious disease. Nature 406: 762-767.
5. COURVALIN, P., and P. TRIEU-CUOT, 2001 Minimizing potential resistance: the molecular view. Clin. Infect. Dis. 33 (Suppl. 3): S138-S146.
6. HALL, B. G., 2002 Predicting evolution by in vitro evolution requires determining evolutionary pathways. Antimicrob. Agents Chemother. 46: 3035-3038.
7. KNOX, J. R., 1995 Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39: 2593-2601.
8. LIVERMORE, D. M., 1996 Are all beta-lactams created equal? Scand. J. Infect. Dis. Suppl. 101: 33-43.
9. MCGOWAN, JR., J. E., 2001 Economic impact of antimicrobial resistance. Emerg. Infect. Dis. 7: 286-292.
10. MEDEIROS, A. A., 1997 Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin. Infect. Dis. 24: S19-S45.
11. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS, 1999 Performance Standards for Antimicrobial Susceptibility Testing: Ninth Informational Supplement. NCCLS Document M100-S9, National Committee for Clinical Laboratory Standards, Wayne, PA.
12. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS, 2001 Performance Standards for Antimicrobial Susceptibility Testing: Supplemental Tables. NCCLS Document M100-S11, National Committee for Clinical Laboratory Standards, Wayne, PA.
13. PERILLI, M., B. SEGATORE, M. R. DE MASSIS, M. L. RICCIO, C. BIANCHI et al., 2000 TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob. Agents Chemother. 44: 2537-2539.
14. REBUCK, J. A., K. M. OLSEN, P. D. FEY, K. L. BERGMAN and M. E. RUPP, 2000 In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host. J. Antimicrob. Chemother. 46: 461-464.
15. STEMMER, W. P. C., 1994 Rapid evolution of a protein in vitro by DNA shuffling. Nature 370: 389-390.
16. VAKULENKO, S. B., B. GERYK, L. P. KOTRA, S. MOBASHERY and S. A. LERNER, 1998 Selection and characterization of beta-lactambeta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene. Antimicrob. Agents Chemother. 42: 1542-1548.
17. YAN, J. J., S. M. WU, S. H. TSAI, J. J. WU and I.J. SU, 2000 Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob. Agents Chemother. 44: 1438-1442.